Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Purpose To evaluate the safety and efficacy of CT-2103, a novel conjugate of paclitaxel and poly-l-glutamic acid, in heavily pretreated patients with recurrent ovarian, fallopian tube, or peritoneal cancer. Patients and Methods Ninety-nine patients with measurable disease received intravenous CT-210...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Paul Sabbatini, Carol Aghajanian, Don S. Dizon, Sybil Anderson, Jakob Dupont, John V. Brown, William A. Peters, Andrew Jacobs, Aminder Mehdi, Saul E. Rivkin, Amy J. Eisenfeld, David R. Spriggs
Médium: Artigo
Jazyk:angličtina
Vydáno: 2004
On-line přístup:https://doi.org/10.1200/jco.2004.12.043
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.12.043?role=tab
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1200/jco.2004.12.043
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.12.043?role=tab

Podobné jednotky